Glutathione-S-transferase variants and adult glioma

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 3, 2004, Pages 461-467

  Wrensch, Margaret ^a,d   Kelsey, Karl T ^b   Liu, Mei ^b   Miike, Rei ^a   Moghadassi, Michelle ^a   Aldape, Kenneth ^c   McMillan, Alex ^a   Wiencke, John K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; PROTEIN P53; UNCLASSIFIED DRUG; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; TUMOR MARKER;

ADULT; ARTICLE; ASTROCYTOMA; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROPATHOLOGY; OLIGODENDROGLIOMA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; AGED; BRAIN TUMOR; DISEASE COURSE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK;

ADULT; AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOMA; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 2442714219     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science, 1999;286:487-91.
2. Yuspa SH, Shields PG. Etiology of cancer: chemical factors. In: De Vita J, Hellman VTS, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 179-93.
3. Harris MJ, Coggan M, Langton L, Wilson SR, Board PG. Polymorphism of the class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics, 1998;8:27-31.
4. Ishimoto TM, Ali-Osman F. Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics, 2002;12:543-53.
5. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-oncol, 2002;4:278-99.
6. Kelsey KT, Wrensch M, Zuo ZF, Miike R, Wiencke JK. A population-based case-control study of the CYP2D6 and GSTT1 polymorphisms and malignant brain tumors. Pharmacogenetics, 1997;7:463-8.
7. Elexpuru-Camiruaga J, Buxton N, Kandula V, et al. Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res, 1995;55:4237-9.
8. De Roos AJ, Rothman N, Inskip PD, et al. Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers & Prev, 2003;12:14-22.
9. Trizna Z, de Andrade M, Kyritsis AP, et al. Genetic polymorphisms in glutathione S-transferase and θ, N-acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiol Biomarkers & Prev, 1998;7:553-5.
10. Wiencke JK, Wrensch MR, Miike R, Zuo Z, Kelsey KT. Population-based study of glutathione S-transferase gene deletion in adult glioma cases and controls. Carcinogenesis, 1997;18:1431-3.
11. Krishnan G, Felini M, Carozza SE, Miike R, Chew T, Wrensch M. Occupation and adult gliomas in the San Francisco Bay Area. J Occup Environ Med, 2003;45:639-47.
12. Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer, 2002;98:609-15.
13. Wrensch M, Lee M, Miike R, et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol, 1997;145:581-93.
14. Smith CM, Kelsey KT, Wiencke JK, Leyden K, Levin S, Christiani DC. Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis. Cancer Epidemiol Biomarkers & Prev, 1994;3:471-7.
15. Chen P, Aldape K, Wiencke JK, et al. Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res, 2001;61:3949-54.
16. SAS/STAT user's guide, version 6. Version 4. Cary (NC): SAS Institute; Inc., 1989
17. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers & Prev, 2001;10:1239-48.
18. Davies SM, Bhatia S, Ross JA, et al. Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood, 2002;100:67-71.
19. Stoehlmacher J, Park DJ, Zhang W, et al. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst, 2002;94:936-42.
20. Voso MT, D'Alo F, Putzulu R, Mele L, et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood, 2002;100:2703-7.
21. Sweeney C, Ambrosone CB, Joseph L, et al. Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment. Int J Cancer, 2003;103:810-4.
22. 6-methylguanine-DNA methyltransferase, glutathione-S-transferase in glioblastoma and the survival of the patients treated with nimustine hydrochloride: an immunohistochemical analysis. Neurol Res, 2003;25:241-8.
23. Sala A, Lanciotti M, Valsecchi MG, et al. Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemia. Leukemia, 2003;17:981-3.
24. Choi SC, Yun KJ, Kim TH, et al. T. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Lett, 2003;195:169-75.
25. Medeiros R, Pereira D, Afonso N, et al. Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome. Int J Clin Oncol, 2003;8:156-61.
26. Miyatake K, Gemba K, Ueoka H, et al. Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase- in patients with unresectable non-small cell lung cancer. Anticancer Res, 2003;23:2829-36.